About Merz Therapeutics
Merz Therapeutics is a Healthcare company based in Frankfurt (Germany). Merz Therapeutics is focused on developing treatments for chronic health conditions. It operates on a Professional Services and Reseller / Distribution model. Merz Therapeutics has completed 1 acquisition, including Acorda. Merz Therapeutics offers products and services including Neurology Treatments, Hepatology Solutions, Dermatology Products, Parkinson's Disease Treatments, and Multiple Sclerosis Therapies. Its focus areas include Pharmaceuticals, Neurology Drugs, Dermatology Drugs and Hepatology Drugs. Its legal entity is Merz Therapeutics GmbH.
Company details
Merz Therapeutics is engaged in the development and distribution of pharmaceutical solutions targeting chronic health conditions. The company specializes in therapeutic fields such as neurology, hepatology, and dermatology. Innovative treatments for movement disorders, Parkinsons disease, and multiple sclerosis are provided alongside patient-centric services. Operations span across multiple regions including Europe, the Middle East, and North America, with a commitment to sustainability and partnerships for enhanced patient outcomes.
- Headquarters Frankfurt, Germany
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website merztherapeutics.com
- Social LinkedIn X
- Legal Name Merz Therapeutics Gmbh
- Investments & Acquisitions
Products & Services of Merz Therapeutics
Merz Therapeutics offers a comprehensive portfolio of products and services, including Neurology Treatments, Hepatology Solutions, Dermatology Products, Parkinson's Disease Treatments, and Multiple Sclerosis Therapies.
Treatments for movement disorders are developed and provided.
Solutions for liver-related conditions are researched and offered.
Products for skin conditions are formulated and distributed.
Specialized treatments for Parkinson's disease are newly introduced.
Therapies for multiple sclerosis are recently added offerings.
Investments & Acquisitions by Merz Therapeutics
Merz Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Acorda.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Engaged in the development and commercialization of therapies that improve neurological function. | acorda.com | Ardsley, United States | 1995 | May 2024 | $185M |
Complete acquisition details for Merz Therapeutics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Merz Therapeutics
Merz Therapeutics is headquartered in Frankfurt, Germany. It is registered at Frankfurt, Hesse, Germany.
Merz Therapeutics is engaged in the development and distribution of pharmaceutical solutions targeting chronic health conditions. The company specializes in therapeutic fields such as neurology, hepatology, and dermatology. Innovative treatments for movement disorders, Parkinsons disease, and multiple sclerosis are provided alongside patient-centric services. Operations span across multiple regions including Europe, the Middle East, and North America, with a commitment to sustainability and partnerships for enhanced patient outcomes.
Merz Therapeutics offers Neurology Treatments, Hepatology Solutions, Dermatology Products, Parkinson's Disease Treatments, and Multiple Sclerosis Therapies.
Merz Therapeutics has made 1 acquisition, including Acorda.
Merz Therapeutics operates through Merz Therapeutics Gmbh.